LAURUSLABS

Laurus Labs Share Price

₹560.20 -16.7 (-2.89%)

22 Jan, 2025 12:08

SIP TrendupStart SIP in LAURUSLABS

Start SIP

Performance

  • Low
  • ₹555
  • High
  • ₹582
  • 52 Week Low
  • ₹361
  • 52 Week High
  • ₹619
  • Open Price₹580
  • Previous Close₹577
  • Volume650,945

Investment Returns

  • Over 1 Month + 0.18%
  • Over 3 Month + 20.41%
  • Over 6 Month + 27.2%
  • Over 1 Year + 39.41%
SIP Lightning

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 230.4
  • PEG Ratio
  • -3.6
  • Market Cap Cr
  • 30,209
  • P/B Ratio
  • 7.3
  • Average True Range
  • 18.32
  • EPS
  • 2.43
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 6.17
  • RSI
  • 50.27
  • MFI
  • 50.34

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹560.20
-16.7 (-2.89%)
pointer
  • stock-down_img
  • Bearish Moving Average 11
  • stock-up_img
  • Bullish Moving Average 5
  • 20 Day
  • ₹579.06
  • 50 Day
  • ₹560.25
  • 100 Day
  • ₹529.17
  • 200 Day
  • ₹491.68

Resistance and Support

581.77 Pivot Speed
  • R3 606.33
  • R2 599.77
  • R1 588.33
  • S1 570.33
  • S2 563.77
  • S3 552.33

What's your outlook on Laurus Labs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 5,053.20 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 5% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 23% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results & Interim Dividend
2024-07-25 Quarterly Results
2024-04-25 Audited Results & Interim Dividend
2024-01-24 Quarterly Results
Date Purpose Remarks
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-05-10 INTERIM Rs.1.20 per share(60%)Interim Dividend
2022-11-04 INTERIM Rs.0.80 per share(40%)Interim Dividend
View More
Date Purpose Remarks
2020-09-30 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.6%
7.62%
4.08%
25.56%
0%
22.74%
12.4%

About Laurus Labs

  • NSE Symbol
  • LAURUSLABS
  • BSE Symbol
  • 540222
  • ISIN
  • INE947Q01028

Similar Stocks to Laurus Labs

Laurus Labs FAQs

Laurus Labs share price is ₹560 As on 22 January, 2025 | 11:54

The Market Cap of Laurus Labs is ₹30208.9 Cr As on 22 January, 2025 | 11:54

The P/E ratio of Laurus Labs is 230.4 As on 22 January, 2025 | 11:54

The PB ratio of Laurus Labs is 7.3 As on 22 January, 2025 | 11:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23